Effective Dose of Ramosetron for Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Patients

Background. Postoperative nausea and vomiting (PONV) are common adverse events with an incidence of up to 80% in high-risk patients. Ramosetron, a selective 5-HT(3) receptor antagonist, is widely used to prevent PONV. The purpose of this study was to evaluate the effective dose of ramosetron for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seongheon, Jeong, Sinho, Kim, Joungmin, Jeong, Seongwook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516817/
https://www.ncbi.nlm.nih.gov/pubmed/26258145
http://dx.doi.org/10.1155/2015/951474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516817/
https://www.ncbi.nlm.nih.gov/pubmed/26258145
http://dx.doi.org/10.1155/2015/951474

Ejemplares similares